148 related articles for article (PubMed ID: 30723672)
21. Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease).
Schorlemmer K; Bauer S; Belke M; Hermsen A; Klein KM; Reif PS; Oertel WH; Kunz WS; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav Case Rep; 2013; 1():118-21. PubMed ID: 25667843
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and serum concentrations of perampanel for treatment of drug-resistant epilepsy in children, adolescents, and young adults: comparison of patients younger and older than 12 years.
Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Koichihara R
Seizure; 2019 Dec; 73():75-78. PubMed ID: 31759296
[TBL] [Abstract][Full Text] [Related]
23. Seizures and EEG characteristics in a cohort of pediatric patients with dystroglycanopathies.
Yang H; Song D; Liu Y; Chen X; Zhu Y; Wei C; Fu X; Liu X; Yang Z; Xiong H
Seizure; 2022 Oct; 101():39-47. PubMed ID: 35863218
[TBL] [Abstract][Full Text] [Related]
24. Add-on perampanel in Lance-Adams syndrome.
Steinhoff BJ; Bacher M; Kurth C; Staack AM; Kornmeier R
Epilepsy Behav Case Rep; 2016; 6():28-9. PubMed ID: 27437182
[TBL] [Abstract][Full Text] [Related]
25. Budget impact of perampanel as adjunctive treatment of uncontrolled partial-onset and primary generalized tonic-clonic seizures in the United States.
Tremblay G; Barghout V; Patel V; Tsong W; Wang Z
Epilepsy Behav; 2017 Mar; 68():196-202. PubMed ID: 28236697
[TBL] [Abstract][Full Text] [Related]
26. Accidental injuries in patients with generalized tonic-clonic seizures. A multicenter, observational, cross-sectional study (QUIN-GTC study).
Salas-Puig X; Iniesta M; Abraira L; Puig J;
Epilepsy Behav; 2019 Mar; 92():135-139. PubMed ID: 30658321
[TBL] [Abstract][Full Text] [Related]
27. Exacerbation of Repetitive Falls Due to Atonic Seizures Following Perampanel Administration.
Maeda A; Neshige S; Katsumata R; Nonaka M; Ishibashi H; Maruyama H
Cureus; 2023 Jun; 15(6):e40818. PubMed ID: 37485229
[TBL] [Abstract][Full Text] [Related]
28. Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy.
Youn SE; Kim SH; Ko A; Lee SH; Lee YM; Kang HC; Lee JS; Kim HD
J Clin Neurol; 2018 Jul; 14(3):296-302. PubMed ID: 29971974
[TBL] [Abstract][Full Text] [Related]
29. Early-childhood progressive myoclonus epilepsy presenting as partial seizures in dentatorubral-pallidoluysian atrophy.
Hattori H; Higuchi Y; Okuno T; Asato R; Fukumoto M; Kondo I
Epilepsia; 1997 Mar; 38(3):271-4. PubMed ID: 9070587
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.
Nishida T; Lee SK; Inoue Y; Saeki K; Ishikawa K; Kaneko S
Acta Neurol Scand; 2018 Apr; 137(4):392-399. PubMed ID: 29250772
[TBL] [Abstract][Full Text] [Related]
31. Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.
Tsai JJ; Wu T; Leung H; Desudchit T; Tiamkao S; Lim KS; Dash A
Acta Neurol Scand; 2018 Apr; 137(4):378-391. PubMed ID: 29214650
[TBL] [Abstract][Full Text] [Related]
32. [Running fit and generalized tonic-clonic seizure are differently controlled by different subtype receptors in the brainstem].
Yasuda S; Ishida N; Higashiyama A; Kato N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):123-8. PubMed ID: 9866827
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive perampanel for glioma-associated epilepsy.
Dunn-Pirio AM; Woodring S; Lipp E; Herndon JE; Healy P; Weant M; Randazzo D; Desjardins A; Friedman HS; Peters KB
Epilepsy Behav Case Rep; 2018; 10():114-117. PubMed ID: 30377587
[TBL] [Abstract][Full Text] [Related]
34. One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability.
Garamendi-Ruiz I; García-García ME; Bertol-Alegre V; Mauri-Llerda JÁ; García-Morales I; Garayoa-Irigoyen V; Agúndez-Sarasola M; De Toledo-Heras M; García-Morales V; García-Gomara MJ; Arcos-Sánchez C; Gago-Veiga A; Escalza-Cortina I; Rueda-Mena E; Muñoz-Fargas E; Santos-Lasaosa S; Oliván-Usieto JA; Julián LD; Gómez-Esteban JC; Marinas-Alejo A
Epileptic Disord; 2016 Jun; 18(2):173-80. PubMed ID: 27238234
[TBL] [Abstract][Full Text] [Related]
35. [Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].
Hamada S; Shimakawa S; Satomura S; Naito E; Hashimoto T
No To Hattatsu; 2014 Nov; 46(6):439-42. PubMed ID: 25558587
[TBL] [Abstract][Full Text] [Related]
36. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of an HPLC-UV Assay for the Therapeutic Monitoring of the New Antiepileptic Drug Perampanel in Human Plasma.
Franco V; Marchiselli R; Fattore C; Tartara E; De Sarro G; Russo E; Perucca E
Ther Drug Monit; 2016 Dec; 38(6):744-750. PubMed ID: 27753779
[TBL] [Abstract][Full Text] [Related]
38. Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model.
Hanada T; Ido K; Kosasa T
Pharmacol Res Perspect; 2014 Oct; 2(5):e00063. PubMed ID: 25505607
[TBL] [Abstract][Full Text] [Related]
39. Perampanel during pregnancy: Description of four cases.
Alicino AM; Falcicchio G; Boero G; Santarcangelo G; Francavilla T; Trojano M; La Neve A
Epilepsy Behav Rep; 2021; 16():100490. PubMed ID: 34761195
[TBL] [Abstract][Full Text] [Related]
40. Preliminary Asian experience of using perampanel in clinical practice.
Chiang HI; Lim SN; Hsieh HY; Cheng MY; Chang CW; Johnny Tseng WE; Li HT; Lin CY; Wu T
Biomed J; 2017 Dec; 40(6):347-354. PubMed ID: 29433838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
